Trials / Withdrawn
WithdrawnNCT04325932
Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis: a Study Based on Whole-brain CTP
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Urinary Kallikrein has an additional effect on enhancing collateral circulation in symptomatic intracranial atherosclerotic patients under clopidogrel and aspirin dual antiplatelet therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Urinary Kallikrein |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-05-01
- Completion
- 2019-07-01
- First posted
- 2020-03-30
- Last updated
- 2020-03-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04325932. Inclusion in this directory is not an endorsement.